Apellis Pharmaceuticals Stock Price - APLS

27.40
1.89 (7.41%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Apellis Pharmaceuticals Inc APLS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
1.89 7.41% 27.40 25.40 27.73 25.75 25.51 15:20:24
Bid Price Ask Price Spread Spread % News
27.40 27.48 0.08 0.29% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,253 399,129 $ 26.63 $ 10,630,133 1,080,175 16.85 - 50.00
Last Trade Time Type Quantity Stock Price Currency
15:20:24 29 $ 27.41 USD

Apellis Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.06B 75.32M $ -127.50M -5.20 - 71.59M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 39.00 5.00%

more financials information »

Apellis Pharmaceuticals News

Loading Messages....

Latest APLS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical APLS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week26.9828.3624.343525.83669,1580.421.56%
1 Month30.7431.0916.8524.651,055,970-3.34-10.87%
3 Months41.4745.0416.8533.47960,270-14.07-33.93%
6 Months23.6650.0016.8533.671,250,2053.7415.81%
1 Year20.1750.0016.8531.60822,8267.2335.85%
3 Years14.5050.0011.4527.51503,89912.9088.97%
5 Years14.5050.0011.4527.51503,89912.9088.97%

Apellis Pharmaceuticals Description

Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.


Your Recent History
NASDAQ
APLS
Apellis Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.